These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7150344)

  • 1. Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man.
    Waring RH; Mitchell SC; Shah RR; Idle JR; Smith RL
    Biochem Pharmacol; 1982 Oct; 31(19):3151-4. PubMed ID: 7150344
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbocisteine sulphoxidation phenotype.
    Waring RH; Mitchell SC
    Lancet; 1990 Jun; 335(8704):1527. PubMed ID: 1972452
    [No Abstract]   [Full Text] [Related]  

  • 3. Polymorphic sulphoxidation of carbocisteine.
    Meese CO; Hofmann U; Eichelbaum M
    Lancet; 1990 Sep; 336(8716):693-4. PubMed ID: 1975882
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals.
    Waring RH; Mitchell SC; O'Gorman J; Fraser M
    Biochem Pharmacol; 1986 Sep; 35(18):2999-302. PubMed ID: 3753512
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.
    Mitchell SC; Waring RH; Haley CS; Idle JR; Smith RL
    Br J Clin Pharmacol; 1984 Oct; 18(4):507-21. PubMed ID: 6487492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of the metabolism of S-carboxymethyl-L-cysteine in man using a novel HPLC-ECD method.
    Karim EF; Millership JS; Temple DJ; Woolfson AD
    Eur J Drug Metab Pharmacokinet; 1988; 13(4):253-6. PubMed ID: 3243319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of congruence of S-carboxymethyl-L-cysteine sulphoxidation and debrisoquine 4-hydroxylation in a Caucasian population.
    Haley CS; Waring RH; Mitchell SC; Shah RR; Idle JR; Smith RL
    Xenobiotica; 1985 May; 15(5):445-50. PubMed ID: 4036168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification.
    Brockmöller J; Staffeldt B; Roots I
    Eur J Clin Pharmacol; 1991; 40(4):387-92. PubMed ID: 2050173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically determined impaired drug sulphoxidation.
    Waring RH; Mitchell SC; Idle JR; Smith RL
    Lancet; 1981 Apr; 1(8223):778. PubMed ID: 6110975
    [No Abstract]   [Full Text] [Related]  

  • 10. The deficiency of sulfoxidation of S-carboxymethyl-L-cysteine.
    Mitchell SC; Waring RH
    Pharmacol Ther; 1989; 43(2):237-49. PubMed ID: 2675135
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulphoxidation of S-carboxymethyl-L-cysteine in the rhesus monkey (Macaca mulatta), cynomologus monkey (Macaca fascicularis), African green monkey (Cercopithecus aethiops) and the marmoset (Callithrix jacchus).
    Mitchell SC; Waring RH; Wilson VL; Idle JR; Autrup H; Harris CC; Ritchie JC; Crothers MJ; Sieber SM
    Comp Biochem Physiol B; 1986; 84(2):143-4. PubMed ID: 3089678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis.
    Davies MH; Ngong JM; Pean A; Vickers CR; Waring RH; Elias E
    J Hepatol; 1995 May; 22(5):551-60. PubMed ID: 7650336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-carboxymethyl-L-cysteine and it (R/S)-S-oxides in beagle dog plasma and hepatic cytosol.
    Panagopoulos P; Mitchell SC; Steventon GB
    Xenobiotica; 2015; 45(12):1047-53. PubMed ID: 26068525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in human metabolism of S-carboxymethylcysteine.
    Waring RH
    Eur J Drug Metab Pharmacokinet; 1980; 5(1):49-52. PubMed ID: 7389752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.
    Emery P; Panayi GS; Huston G; Welsh KI; Mitchell SC; Shah RR; Idle JR; Smith RL; Waring RH
    J Rheumatol; 1984 Oct; 11(5):626-32. PubMed ID: 6334741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses of metabolites of S-carboxymethyl-L-cysteine and S-methyl-L-cysteine and of some isotopically labelled (2H, 13C) analogues.
    Meese CO; Specht D; Hofmann U
    Arch Pharm (Weinheim); 1990 Dec; 323(12):957-65. PubMed ID: 2096798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracing the human metabolism of stable isotope-labelled drugs by ex vivo NMR spectroscopy. A revision of S-carboxymethyl-L-cysteine biotransformation.
    Meese CO; Fischer P
    Z Naturforsch C J Biosci; 1990; 45(11-12):1171-5. PubMed ID: 2095787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the "major" polymorphic carbocysteine metabolite as S-(carboxymethylthio)-L-cysteine.
    Meese CO; Fischer C; Küpfer A; Wisser H; Eichelbaum M
    Biochem Pharmacol; 1991 Oct; 42(10):R13-6. PubMed ID: 1741762
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacogenetics of the S-oxidation of S-carboxymethyl-L-cysteine.
    Waring RH
    Drug Metabol Drug Interact; 1988; 6(3-4):253-63. PubMed ID: 3078290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPLC-analysis of S-carboxymethylcysteine and its sulphoxide metabolites.
    Brockmöller J; Simane ZJ; Roots I
    Drug Metabol Drug Interact; 1988; 6(3-4):447-56. PubMed ID: 3271650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.